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Carisoprodol, used as a centrally acting
muscle relaxant and analgesic, crosses the
placenta and is concentrated in breast
milk. Because other carbamates have pro-
duced reproductive toxicity, CAR was
tested for its effects on reproduction and
fertility in Swiss CD-1 mice, following the
RACB protocol (Grizzle et al., Fundam
AppI Toxicol 24:132-139 [1995]). Data
on body weights, food and water con-
sumption, and clinical signs were gathered
in the Task 1 dose-range-finding study
and used to set exposure concentrations
for Task 2 of 300, 750, and 1200 mg/kg
by gavage. Feed and water consumption
were increased only at the top dose by 10
to 20%. The top dose induced consider-
able lethargy for the first 3 to 4 weeks of
dosing, after which the incidence and
severity ofthis effect abated.
During Task 2, dam weight at delivery
in the high dose females was reduced at the
fourth and fifth litters (by6 and 7%, respec-
tively). Sireweights were notaffected during
Task 2. While there was no treatment-
related change in the mean numberoflitters
per pair, the number oflive pups per litter,
or viability, there was a 7% reduction in
pupweightadjusted forlittersize.
A crossover mating trial was performed
using the control and high dose mice.
There were no differences between any of
the groups: the number andweight ofpups
were unchanged, as were the mating and
fertilityindices.
After the Task 3 pups were delivered
and evaluated, the control and high dose
Fo mice were killed and necropsied. There
was no treatment-related effect on male
body weights or organ weights, with the
exception of increased weights for liver
(23%) and epididymis (11%). There were
no changes induced in any sperm measure.
For females, there was a 16% reduction in
the body weight of the treated mice; no
other differences were observed. No treat-
ment-related microscopic lesions were
observed in the liver, kidney, adrenals, or
reproductive organs.
The last litter in Task 2 from all dose
groups was reared by their dams until
weaning, when they began receiving the
same dose of CAR administered to their
parents. During the nursing period, there
was increased mortality offemale pups in
the middle dosegroup only, to a maximum
of 13% loss ofpups. Bodyweight at wean-
ing was reduced by 11% (all treated
females) and 12% (high dose males).
When the Fl mice at all dose levels
were mated within dose groups at approxi-
mately 74 days of age, there was, at the
high dose, a 22% reduction in the number
oflive pups per litter, and a 7% reduction
in adjusted live pup weight. Postpartum F1
dam weights were reduced in the low and
high doses by 6 and 7%, respectively. Feed
and water consumption by the Fl adults
was increased by 12 to 20% in the middle
and high dose groups, respectively.
After delivery of the F2 pups and a
short recovery period, the females were
subject to vaginal lavage for 12 days, and
then the adult Fl mice from all dose levels
were killed and necropsied. Male body
weights were reduced in the middle and
high dose groups by 6 and 9%, respec-
tively. Adjusted liver weights in those same
groups ofmales were increased by 10 and
20%, respectively. Right testis weight was
reduced by 12% at the high dose level.
There was no difference in anysperm mea-
sure. Female bodyweights were reduced by
5, 6, and 8% (low to high dose levels),
while relative liver weights were increased
by 8, 13, and 18%, respectively. Therewere
no observed changes in estrous cyclicityend
points. There were no treatment-related
microscopic lesions noted in the livers,
kidneys, adrenals, or reproductive organs.
Incidental macroscopic lesions were noted,
scattered among the dose groups, and not
considered treatment related.
In summary, carisoprodol produced
reproductive toxicity in the second genera-
tion (reduced F2 pup number and weight)
at exposure levels that produced significant
behavioral effects initially and alterations in
somatic and organweights.
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Summary: NTP Reproductive Assessment byContinuous Breeding Study.
NTIS#: 92128404
Chemical: Carisoprodol
CAS#: 78-44-4
Mode ofexposure: Gavage
Species/strain: Swiss CD-1 mice
F generation Dose concentration 300 mg/kg 750mg/kg 1200mg/kg
Bodyweight -,
Kidneyweight8 e .
Liverweight8 - 1
Mortality T. .t
Feedconsumption -
Waterconsumption
Clinical signs
,S ... .. ... ...................
li fters/pair
#livepups/litter; pupwt./litter -
Cumulativedaysto lifter _ .
Absolutetestis, epididymisweighta *
Sex accessoryglandweighta(prostate, seminal vesicle) * * - .
Epidid. sperm parameters (#,motility, morphology) -
Estrouscycle length .
[Determination ofaffected sex(crossover) ] Male Female [ Both
Dose level - ---'--'--_
F generation Dose concentration- 300mg/kg 750mg/kg I200mg/kg
Pup growth to weaning
Mortality
Adultbodyweight -.4 , ,
Kidneyweighta -. = - -
Liverweighta t ti, t,t
Feed consumption T --- t, T
Waterconsumption T _t, --_---___---__
Clinical signs _- __
* . . . . . . . I~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------
Fertility index _
#livepups/lifter; pupwt./litter - f
Absolutetestis, epididymisweight8 _. _ I -__
Sexaccessoryglandweight8(prostate, seminalvesicle) , -
Epidid. sperm parameters($,motility, morphology) _ _ -
Estrous cycle length_
Affected sex? Unclear
Studyconfounders: None
NOAELreproductivetoxicity: 750mg/kg
NOAELgeneraltoxicity: <300mg/kg
F1 more sensitivethanFo? Yes
Postnataltoxicity: Yes
Legend: -, no change; *, no observation; T or4, statistically significant change(p<0.05); , no change in males orfemales. 'Adjusted for bodyweight.
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